Literature DB >> 21185256

Carbon metabolism and the sign of control coefficients in metabolic adaptations underlying K-ras transformation.

Pedro de Atauri1, Adrian Benito, Pedro Vizán, Miriam Zanuy, Ramón Mangues, Silvia Marín, Marta Cascante.   

Abstract

Metabolic adaptations are associated with changes in enzyme activities. These adaptations are characterized by patterns of positive and negative changes in metabolic fluxes and concentrations of intermediate metabolites. Knowledge of the mechanism and parameters governing enzyme kinetics is rarely available. However, the signs-increases or decreases-of many of these changes can be predicted using the signs of metabolic control coefficients. These signs require the only knowledge of the structure of the metabolic network and a limited qualitative knowledge of the regulatory dependences, which is widely available for carbon metabolism. Here, as a case study, we identified control coefficients with fixed signs in order to predict the pattern of changes in key enzyme activities which can explain the observed changes in fluxes and concentrations underlying the metabolic adaptations in oncogenic K-ras transformation in NIH-3T3 cells. The fixed signs of control coefficients indicate that metabolic changes following the oncogenic transformation-increased glycolysis and oxidative branch of the pentose-phosphate pathway, and decreased concentration in sugar-phosphates-could be associated with increases in activity for glucose-6-phosphate dehydrogenase, pyruvate kinase and lactate dehydrogenase, and decrease for transketolase. These predictions were validated experimentally by measuring specific activities. We conclude that predictions based on fixed signs of control coefficients are a very robust tool for the identification of changes in enzyme activities that can explain observed metabolic adaptations in carbon metabolism.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185256     DOI: 10.1016/j.bbabio.2010.11.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.

Authors:  Laura Brunelli; Elisa Caiola; Mirko Marabese; Massimo Broggini; Roberta Pastorelli
Journal:  Oncotarget       Date:  2014-07-15

3.  Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome.

Authors:  Adrián Benito; Ibrahim H Polat; Véronique Noé; Carlos J Ciudad; Silvia Marin; Marta Cascante
Journal:  Oncotarget       Date:  2017-10-07

Review 4.  Metabolic Alterations in Cardiopulmonary Vascular Dysfunction.

Authors:  Valérie Françoise Smolders; Erika Zodda; Paul H A Quax; Marina Carini; Joan Albert Barberà; Timothy M Thomson; Olga Tura-Ceide; Marta Cascante
Journal:  Front Mol Biosci       Date:  2019-01-22

Review 5.  A Comparative Analysis of Individual RAS Mutations in Cancer Biology.

Authors:  Carmen Muñoz-Maldonado; Yitzhak Zimmer; Michaela Medová
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

6.  TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.

Authors:  Inês Baptista; Effrosyni Karakitsou; Jean-Baptiste Cazier; Ulrich L Günther; Silvia Marin; Marta Cascante
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

7.  Induction of oxidative metabolism by the p38α/MK2 pathway.

Authors:  Natalia Trempolec; Juan Pablo Muñoz; Konstantin Slobodnyuk; Silvia Marin; Marta Cascante; Antonio Zorzano; Angel R Nebreda
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

8.  The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.

Authors:  Juan M Barajas; Ryan Reyes; Maria J Guerrero; Samson T Jacob; Tasneem Motiwala; Kalpana Ghoshal
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.